Two-hour event starts 08:00 New York / 13:00 London / 14:00 Zürich
"BresMed and Cello Health are delighted to host a new joint global Pharma Progress conference. The first in a series of virtually enabled, short and focused events dedicated to highlighting some of healthcare's most imperative challenges and discussing the most relevant innovative solutions to address them."
Increasingly a mainstay of clinical and commercial planning, we explore how the patient journey is influencing decision making in pharma, whether the patient voice is being clearly represented and how this is impacting patient outcomes. At a time when there are intense healthcare challenges and a reprioritization of health budgets, we also look at whether COVID-19 has fundamentally changed the patient journey, and the implications for pharma.
Chair, Patient and Public Voices Forum, NHS England Cancer Programme; Director of Partnerships and Evaluation, Shine.
Starting with patients in mind - how do they feel their needs are being heard? What is working well and how pharma and healthcare can improve.
Patient Engagement & Advocacy Lead, Europe, Middle-East and Africa, Janssen.
Head of EMEA Marketing & Operations at Novartis Gene Therapies, Novartis.
How the patient journey and voice are finding new meaning in pharma. We explore the challenges and opportunities from the perspective of two leading pharma companies.
President, Patient Insights, Cello Health.
Emerging trends in how COVID-19 is impacting patient journeys and implications for pharma.
Opportunity for attendees to ask questions directly to speakers and panellists.